Delivery Order SPE2DB20D3103-SPE2DB25FQ3K0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Kineret 100 mg/0.67 mL syringes with a ceiling value of $11,637.86 under a firm fixed price arrangement. This delivery order, which is a child contract under AmerisourceBergen's larger pharmaceutical supply agreement, will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. The award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes with a ceiling value of $10,742.64 under a firm fixed-price arrangement. The order, issued on May 15, 2025, carries an ultimate completion date of June 6, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a $4,476.10 delivery order to AmerisourceBergen Drug Corp for Kineret 100 mg/0.67 mL syringes on June 5, 2025, with an ultimate completion date of June 27, 2025. This firm fixed-price contract, which is non-set-aside and competitively awarded, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. This firm fixed price delivery order, valued at approximately $14.3K, is scheduled for completion by September 16, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $2,685.66 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 ml syringes. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure. Performance will be completed by August 28, 2025, with the contract issued on August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,323.52 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes on July 23, 2025, with completion expected by August 13, 2025. This is a firm fixed-price delivery order issued under a competitively awarded indefinite delivery contract. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award reflects no set-aside designation, indicating it...
- The Defense Logistics Agency awarded a delivery order valued at $1,790.44 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes. This competitive, non-set-aside contract utilizes firm fixed pricing and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of May 30, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Kineret 100 mg/0.67 mL syringes, with a ceiling value of $11,637.86 and firm fixed pricing. This delivery order, which is not set-aside designated, represents a competitive award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 ml syringes on June 20, 2025, with a ceiling value of $3,580.88 and an ultimate completion date of July 14, 2025. This competitively awarded, non-set-aside delivery order employs firm fixed price pricing and is executed from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Kineret 100 mg/0.67 mL syringes totaling $14,323.52, with completion targeted for May 15, 2025. The contract utilizes firm fixed pricing with no set-aside designation, reflecting competitive award procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3K0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Kineret 100 mg/0.67 mL syringes, with a ceiling value of $14,323.52. The contract was competitively awarded without set-aside on September 16, 2025, with an ultimate completion date of October 7, 2025. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order utilizes a firm fixed-price contract type, providing pricing certainty for the government. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen serves the military and veteran healthcare systems with an extensive portfolio of medications and medical supplies. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply branded and generic drugs, vaccines, and specialty medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 9/16/25 |